Search Results for: stem cells for MS

What are induced pluripotent stem cells or IPS cells?

induced pluripotent stem cells clinical trials map

Induced pluripotent stem cells or iPS cells just might be the most exciting development in the stem cell field over the last 15 years. They have unique potential for clinical impact for regenerative medicine too. This may manifest both through their use to produce differentiated cellular therapies and indirectly via disease modeling as well as […]

What are induced pluripotent stem cells or IPS cells? Read More »

21 Stem Cell Research & Regenerative Medicine 2021 Predictions

stem-cell-crystal-ball-300x3001

In any given field of biomedical science like stem cell research and regenerative medicine, it’s very useful if you can accurately predict the future. It seems, though, that predictions are far more difficult within the more exciting and rapidly-changing fields. The field of stem cells and regenerative medicine fits that bill. Past stem cell research

21 Stem Cell Research & Regenerative Medicine 2021 Predictions Read More »

Small umbilical cord stem cell COVID-19 trial: sign of efficacy?

stem cells for autism

A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new study such as one of the authors describing the

Small umbilical cord stem cell COVID-19 trial: sign of efficacy? Read More »

Recommended reads: MSCs, vision, endothelial cells, more

wang et al 2020 science advances

What a year 2020 was, but there was still plenty of great science, which continues now in 2021 including published research like today’s recommended pieces and there’s one thread on MSCs today. The Niche new look, more features, and a Medical Advisory Board for 2021 Before we get to the recommended reads, note that 2021

Recommended reads: MSCs, vision, endothelial cells, more Read More »

Stem cells seed a new thymus, clinical hope?

thymus, stem cells, bioengineering

Imagine receiving a smidgeon of thymus gland along with a donated heart or kidney, to fool the immune system into accepting the transplant. Authors of a new study argue that might be possible, based on their new proof-of-principle experiments. The team from the Epithelial Stem Cell Biology and Regenerative Medicine lab at the Francis Crick

Stem cells seed a new thymus, clinical hope? Read More »

Spicy stem cell pathways & other recommended reads

Nociceptor-mediated HSC mobilization. "Schematic representation showing that nociceptive-nerve-derived CGRP, but not substance P, acts via CGRP receptors on HSCs to enhance their mobilization via a cAMP-mediated signalling pathway. "Gao et al Nature, Capsaicin acts via nociceptor signaling to mobilize blood stem cells.

The stem cell paper of the week is a fun one about how capsaicin and nociceptors reportedly mobilize blood stem cells.  However, since the authors only show this in mice, could it also happen in humans? They argue it’s likely happening in people too. Note that nociceptors are special structures in our bodies that sense

Spicy stem cell pathways & other recommended reads Read More »

What are totipotent stem cells & what can they do?

Multipotent & totipotent vs pluripotent stem cells, very early human embryos totipotent stem cells

Sometimes patients or my students ask me, “What are the best stem cells?” what information are they looking for? I think they often are looking for the most powerful stem cells so perhaps they should be asking, “What are totipotent stem cells?” Other times it seems what patients specifically want to know is what might

What are totipotent stem cells & what can they do? Read More »

Mesoblast stock hit on gloomy data on stem cells for COVID-19

mesoblast ceo dr silvio itescu

I’ve been closely following the arena of stem cells for COVID-19 since the pandemic broke including the efforts of Mesoblast. Mesoblast unlikely to meet primary endpoints in Phase III COVID trial Now, the firm got bad news as its DSMB reported that they are unlikely to meet the primary endpoint for their Phase III trial

Mesoblast stock hit on gloomy data on stem cells for COVID-19 Read More »

Our Educational Mission on The Niche Stem Cell Site

KnoepflerStemSymbol

Our mission here on The Niche is primarily educational. We aim to make a transformative difference in educating readers across the globe about stem cells, regenerative medicine, and innovative biomedical science more generally including CRISPR gene editing. A major part of that mission involves fact-checking various medical claims about stem cells and other biologics like

Our Educational Mission on The Niche Stem Cell Site Read More »